Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
*Includes escrow
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cardiovascular
Neuroprotection
Drug Discovery
Inflammation/Pain
Autoimmune
Technical Glossary
Publications
Investors
Investor Welcome
ASX Announcements
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
News & Insights
Presentations & Interviews
Media
Newsletters
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
ASX Announcements
Filter by Year:
2022
2021
2020
20-Jan-2020
Becoming a substantial holder
17-Jan-2020
Nyrada Inc - Corporate Presentation
16-Jan-2020
NOX: Listing of Nyrada Inc. spin-off on ASX
16-Jan-2020
NYR Commences Trading on the ASX
16-Jan-2020
Becoming a substantial holder
16-Jan-2020
Becoming a substantial holder
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
Previous
1
2
3
4
5
6
7
8
Next
